Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
about
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOSImpact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-AnalysisHormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies.
P2860
Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Novel inflammatory markers in ...... pharmacological intervention.
@en
Novel inflammatory markers in ...... pharmacological intervention.
@nl
type
label
Novel inflammatory markers in ...... pharmacological intervention.
@en
Novel inflammatory markers in ...... pharmacological intervention.
@nl
prefLabel
Novel inflammatory markers in ...... pharmacological intervention.
@en
Novel inflammatory markers in ...... pharmacological intervention.
@nl
P2093
P2860
P356
P1476
Novel inflammatory markers in ...... pharmacological intervention.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03345790
P50
P577
2009-10-15T00:00:00Z
P6179
1025482371